Polymyalgia rheumatica (PMR) is an inflammatory disorder of unknown aetiology that can be extremely disabling when active. Glucocorticoids are currently the therapy of choice for patients with PMR, but responsiveness to treatment varies considerably. The identification of different morphological patterns of disease defined by distinct extracapsular or capsular-based inflammation might, at least in part, explain this variability in responses to treatment.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Magnetic resonance imaging in polymyalgia rheumatica—contrast enhancement is not always needed
Zeitschrift für Rheumatologie Open Access 11 August 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dejaco, C. et al. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann. Rheum. Dis. 74, 1799–1807 (2015).
Hutchings, A. et al. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum. 57, 803–809 (2007).
Mackie, S. L., Hensor, E. M., Haugeberg, G., Bhakta, B. & Pease, C. T. Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study. Rheumatology (Oxford) 49, 716–722 (2010).
Mackie, S. L. et al. Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2015-207395.
Falsetti, P., Acciai, C., Volpe, A. & Lenzi, L. Ultrasonography in early assessment of elderly patients with polymyalgic symptoms: a role in predicting diagnostic outcome? Scand. J. Rheumatol. 40, 57–63 (2011).
Dasgupta, B. et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann. Rheum. Dis. 71, 484–492 (2012).
Jimenez-Palop, M. et al. Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica. Ann. Rheum. Dis. 69, 879–882 (2010).
Macchioni, P., Catanoso, M. G., Pipitone, N., Boiardi, L. & Salvarani, C. Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) 48, 1566–1569 (2009).
Salvarani, C. et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann. Rheum. Dis. 67, 758–761 (2008).
Matteson, E. L. et al. Patient-reported outcomes in polymyalgia rheumatica. J. Rheumatol. 39, 795–803 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Buttgereit, F., Matteson, E. Whole-body MRI undresses polymyalgia rheumatica. Nat Rev Rheumatol 12, 140–141 (2016). https://doi.org/10.1038/nrrheum.2015.163
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2015.163
This article is cited by
-
Magnetic resonance imaging in polymyalgia rheumatica—contrast enhancement is not always needed
Zeitschrift für Rheumatologie (2023)